down arrow

Glenmark Pharma

47
Sell
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE935A01035
  • NSEID: GLENMARK
  • BSEID: 532296
INR
1,370.20
-6.15 (-0.45%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.46 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
11,813.00
11,583.00
12,304.00
10,943.00
10,640.00
9,865.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
11,813.00
11,583.00
12,304.00
10,943.00
10,640.00
9,865.00
Expenditure (Ex Depriciation)
Stock Adjustments
-195.00
-240.00
-11.00
-189.00
128.00
-58.00
Raw Materials Consumed
4,608.00
4,498.00
4,396.00
3,888.00
3,570.00
3,421.00
Power & Fuel Cost
123.00
111.00
200.00
164.00
173.00
165.00
Employee Cost
2,868.00
2,600.00
2,447.00
2,343.00
2,254.00
2,056.00
Operating Expenses
751.00
580.00
711.00
725.00
594.00
646.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1,092.00
1,137.00
896.00
979.00
1,005.00
1,125.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
751.00
645.00
696.00
436.00
554.00
299.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
10,617.00
9,948.00
9,984.00
8,859.00
8,942.00
8,279.00
Operating Profit (PBDIT) excl Other Income
1,195.00
1,635.00
2,320.00
2,084.00
1,698.00
1,585.00
Other Income
839.00
288.00
166.00
50.00
159.00
208.00
Operating Profit (PBDIT)
2,035.00
1,923.00
2,486.00
2,134.00
1,857.00
1,793.00
Interest
515.00
349.00
298.00
353.00
377.00
334.00
Profit before Depriciation and Tax
1,519.00
1,574.00
2,188.00
1,781.00
1,480.00
1,459.00
Depreciation
581.00
569.00
486.00
443.00
417.00
325.00
Profit Before Taxation & Exceptional Items
937.00
1,005.00
1,702.00
1,337.00
1,063.00
1,133.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
36.00
239.00
1,441.00
1,382.00
1,096.00
1,300.00
Provision for Tax
1,867.00
329.00
447.00
412.00
320.00
375.00
Profit After Tax
-1,830.00
-89.00
993.00
970.00
775.00
924.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
9,457.00
9,210.00
7,233.00
6,329.00
5,614.00
4,779.00
Profit Available for appropriations
7,558.00
9,041.00
8,175.00
7,299.00
6,390.00
5,704.00
Appropriations
7,558.00
9,041.00
8,175.00
7,299.00
6,390.00
5,704.00
Equity Dividend (%)
250.00%
250.00%
250.00%
250.00%
250.00%
200.00%
Earnings Per Share
-53.22
10.53
33.37
34.38
27.50
32.78
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 1.98% vs -5.86% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is -26.89% vs -29.53% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 47.83% vs 17.09% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is -1,944.25% vs -109.01% in Mar 2023

Compare Profit and Loss Results of Glenmark Pharma
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
11,813.00
10,334.00
1,479.00
14.31%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
11,813.00
10,334.00
1,479.00
14.31%
Expenditure (Ex Depriciation)
Stock Adjustments
-195.00
-94.00
-101.00
-107.45%
Raw Materials Consumed
4,608.00
3,263.00
1,345.00
41.22%
Power & Fuel Cost
123.00
129.00
-6.00
-4.65%
Employee Cost
2,868.00
2,274.00
594.00
26.12%
Operating Expenses
751.00
210.00
541.00
257.62%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1,092.00
928.00
164.00
17.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
751.00
134.00
617.00
460.45%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
10,617.00
7,798.00
2,819.00
36.15%
Operating Profit (PBDIT) excl Other Income
1,195.00
2,536.00
-1,341.00
-52.88%
Other Income
839.00
280.00
559.00
199.64%
Operating Profit (PBDIT)
2,035.00
2,817.00
-782.00
-27.76%
Interest
515.00
35.00
480.00
1,371.43%
Profit before Depriciation and Tax
1,519.00
2,782.00
-1,263.00
-45.40%
Depreciation
581.00
398.00
183.00
45.98%
Profit Before Taxation & Exceptional Items
937.00
2,384.00
-1,447.00
-60.70%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
36.00
2,399.00
-2,363.00
-98.50%
Provision for Tax
1,867.00
457.00
1,410.00
308.53%
Profit After Tax
-1,830.00
1,926.00
-3,756.00
-195.02%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
9,457.00
8,012.00
1,445.00
18.04%
Profit Available for appropriations
7,558.00
9,925.00
-2,367.00
-23.85%
Appropriations
7,558.00
9,925.00
-2,367.00
-23.85%
Equity Dividend (%)
250%
0%
250.00
Earnings Per Share
-53.22
47.75
-100.97
-211.46%
Profit And Loss - Net Sales
Net Sales 11,813.10 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 1.98% vs -5.86% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,195.33 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -26.89% vs -29.53% in Mar 2023

Profit And Loss - Interest
Interest 515.97 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 47.83% vs 17.09% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax -1,830.85 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -1,944.25% vs -109.01% in Mar 2023